TY  - JOUR

T1  - TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer.

JO  - Health Technology Assessment

UR  - https://eprints.whiterose.ac.uk/id/eprint/104845

UR  - http://dx.doi.org/10.3310/hta20530

PY  - 2016/07/01

AU  - James N

AU  - Pirrie S

AU  - Pope A

AU  - Barton D

AU  - Andronis L

AU  - Goranitis I

AU  - Collins S

AU  - McLaren D

AU  - O'Sullivan J

AU  - Parker C

AU  - Porfiri E et al

ED  - 

DO  - DOI: 10.3310/hta20530

PB  - NIHR Health Technology Assessment Programme

VL  - 20

Y2  - 2025/12/05

ER  -